ClinicalTrials.gg
CompletedNCT07168577CP-SLEEPUpdated Nov 3, 2026

Sleep Quality and Caregiver Burden in Children With Cerebral Palsy

An observational study in Cerebral Palsy, Sleep Disorders in Children and Caregiver Burden, sponsored by Selim Sezikli. Completed at 1 site in Turkey (Türkiye). Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Selim Sezikli · Observational

How we know

Updated Oct 27, 2026Eligibility revisedPrimary outcomes revised+6 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
61
Ages
2 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 328 studies in Cerebral Palsy with a site in Turkey — 43 open to participants now, 50 under way, none of them phase 3. Cerebral Palsy · Turkey.

Enrollment
71st of 138
61 · median 63
Started
2025
with 30 others
Observational
138 of 328
13 open now
Registered
284th of 328
by date

Among the 328 studies in Cerebral Palsy with a site in Turkey, this one is the 71st largest by enrollment of the 138 observational ones that give a count, is one of 31 that started in 2025, is one of 138 observational ones, and was the 284th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

43 of the 328 studies in Cerebral Palsy with a site in Turkey are open now. Recruiting first, the newest first:

38 more — sign in →

All 43 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 2 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 328 studies in Cerebral Palsy with a site in Turkey, or all of them as a file.
02

Study summary

Cerebral palsy (CP) is a lifelong condition affecting movement and posture, often requiring substantial care from family members. Children with CP frequently experience sleep disturbances associated with motor impairment, pain, seizures, and other clinical factors. Sleep difficulties may also be associated with poor sleep quality, psychological symptoms, and increased burden among caregivers.

This single-center, observational, cross-sectional study evaluated sleep characteristics in children with CP, caregiver sleep quality, and caregiver burden, as well as their associations with functional status and caregiver psychological symptoms.

The study included 61 children with CP and their primary caregivers. Eligible children were aged 2-18 years. Children's sleep characteristics were assessed using a 33-item parent-reported questionnaire adapted from the Children's Sleep Habits Questionnaire (CSHQ), which was not identical to the validated Turkish CSHQ. Children's functional characteristics were evaluated using GMFCS, MACS, and CFCS. Caregiver sleep quality, caregiver burden, and psychological symptoms were assessed using the Pittsburgh Sleep Quality Index (PSQI), Zarit Burden Interview (ZBI), and Hospital Anxiety and Depression Scale (HADS), respectively.

The study was designed to examine associations among child sleep characteristics, caregiver sleep quality, caregiver burden, and psychological well-being.

Read the detailed description

Cerebral palsy (CP) is a common cause of motor disability in childhood and is frequently associated with long-term care needs. Sleep disturbances are common among children with CP and may coexist with motor impairment, epilepsy, pain, and behavioral difficulties. Caregivers may experience substantial physical and psychological demands, including sleep problems, anxiety, depressive symptoms, and caregiver burden.

This single-center, observational, cross-sectional study was conducted in the outpatient Physical Medicine and Rehabilitation clinics of Istanbul Physical Medicine and Rehabilitation Training and Research Hospital, Türkiye. The study initially planned to recruit at least 40 child-caregiver pairs. Data collection was completed with 61 children diagnosed with CP and their primary caregivers. Participants were recruited through convenience sampling and voluntary participation.

Children were eligible if they were aged 2-18 years with a diagnosis of CP and their adult primary caregivers were evaluated. Children's functional characteristics were classified using the Gross Motor Function Classification System (GMFCS), Manual Ability Classification System (MACS), and Communication Function Classification System (CFCS). Spasticity was evaluated using the Modified Ashworth Scale.

Children's sleep characteristics were assessed using a 33-item parent-reported questionnaire adapted from the Children's Sleep Habits Questionnaire (CSHQ). The questionnaire administered in this study differed in item wording and scoring structure from the validated Turkish CSHQ; therefore, the resulting scores should not be considered directly equivalent to those obtained from the validated instrument.

Caregiver sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), caregiver burden using the Zarit Burden Interview (ZBI), and anxiety and depressive symptoms using the Hospital Anxiety and Depression Scale (HADS).

The study examined associations among children's sleep characteristics, functional status, caregiver sleep quality, caregiver burden, and psychological symptoms using descriptive and inferential statistical methods. Analyses involving the adapted child sleep questionnaire were interpreted as exploratory because of differences from the validated CSHQ instrument.

03

Conditions studied

  • Cerebral Palsy
  • Sleep Disorders in Children
  • Caregiver Burden
  • Sleep Quality
  • Anxiety and Depression (Caregivers)

Keywords

  • Zarit Burden Interview (ZBI)
  • Cerebral palsy
  • Sleep quality
  • Pittsburgh Sleep Quality Index (PSQI)
  • Sleep disorders
  • Caregiver burden
  • Caregiver sleep quality
  • Adapted Child Sleep Questionnaire
04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consisted of children aged 2-18 years diagnosed with cerebral palsy and their primary caregivers (parents or legal guardians aged 18 years or older). Participants were recruited from the outpatient clinics of Istanbul Physical Medicine and Rehabilitation Training and Research Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 2-18 years with a confirmed diagnosis of cerebral palsy
  • Primary caregiver (≥18 years, parent or legal guardian) responsible for the child's daily care
  • Ability to read and write in Turkish
  • Sufficient cognitive capacity to complete questionnaires and participate in interviews
  • Voluntary agreement of both the child's caregiver and participant to join the study

Exclusion criteria

Exclusion Criteria:

  • Presence of severe comorbid neurological or metabolic disease in the child
  • Caregiver with a history of severe psychiatric disorder or cognitive impairment
  • Communication problems that prevent completion of questionnaires
  • Hospitalization within the last 3 months due to acute medical condition
  • Withdrawal of consent or incomplete questionnaires during the study
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
61 participants (actual)
Patient registry
No

Groups and cohorts

  • Children With Cerebral Palsy and Primary Caregivers

    This group comprised 61 children aged 2-18 years with cerebral palsy and their primary caregivers. Children underwent functional assessments using GMFCS, MACS, and CFCS, and spasticity assessment using the Modified Ashworth Scale. Children's sleep characteristics were evaluated using a 33-item questionnaire adapted from the CSHQ. Caregiver sleep quality, caregiver burden, and psychological symptoms were assessed using the PSQI, ZBI, and HADS, respectively. No experimental intervention was administered.

06

What researchers measure

Primary outcomes

  1. Child Sleep Quality Assessed by a 33-Item Parent-Reported Questionnaire Adapted From the Children's Sleep Habits Questionnaire (CSHQ)

    Sleep characteristics of children with cerebral palsy were assessed using a 33-item parent-reported questionnaire adapted from the CSHQ. The questionnaire administered differed from the validated Turkish CSHQ in item wording, ordering and scoring, so the scores are not equivalent to those of the validated instrument and analyses involving this measure were exploratory.

    Time frame: Day 1 (single assessment at baseline)

  2. Caregiver Sleep Quality Assessed by Pittsburgh Sleep Quality Index (PSQI)

    Caregiver sleep quality was measured using the Pittsburgh Sleep Quality Index (PSQI), which evaluates sleep patterns and disturbances over the previous month.

    Time frame: Day 1 (single assessment at baseline)

  3. Caregiver Burden Assessed by Zarit Burden Interview (ZBI)

    Caregiver burden was assessed using the Zarit Burden Interview (ZBI), a validated questionnaire evaluating the impact of caregiving on emotional, physical, and social well-being.

    Time frame: Day 1 (single assessment at baseline)

Secondary outcomes

  1. Child Functional Level Assessed by Gross Motor Function Classification System (GMFCS)

    Functional motor levels of the children were classified according to the GMFCS, a standardized 5-level system describing gross motor function.

    Time frame: Day 1 (single assessment at baseline)

  2. Manual Ability Assessed by Manual Ability Classification System (MACS)

    Hand function and manual ability of the children were evaluated using the MACS, a validated classification system for children with cerebral palsy.

    Time frame: Day 1 (single assessment at baseline)

  3. Communication Function Assessed by Communication Function Classification System (CFCS)

    Communication ability of the children was assessed using the CFCS, which categorizes functional communication performance in daily life.

    Time frame: Day 1 (single assessment at baseline)

  4. Spasticity Assessed by Modified Ashworth Scale (MAS)

    Muscle spasticity was measured using the Modified Ashworth Scale (MAS), a widely used clinical tool for grading resistance to passive movement.

    Time frame: Day 1 (single assessment at baseline)

  5. Caregiver Psychological Status Assessed by Hospital Anxiety and Depression Scale (HADS)

    Caregivers' psychological health was evaluated using the HADS, a self-reported screening tool for symptoms of anxiety and depression.

    Time frame: Day 1 (single assessment at baseline)

07

Study locations

1 site
  • Istanbul Physical Medicine and Rehabilitation Training and Research Hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the published results will be shared, comprising the children's clinical and functional characteristics and the caregiver-reported questionnaire scores. Direct identifiers have been removed; the dataset is pseudonymised rather than fully anonymous.

Supporting information: Study protocol, Informed consent form

Time frame: Available from December 2026 to December 2028, beginning after publication of the main results.

Access criteria: Qualified researchers may request access from the principal investigator. Access requires independent research ethics committee approval, a signed data use agreement, and compliance with consent and confidentiality requirements. No open repository deposit.

No publications or documents are linked to this record.

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jul 2025 to primary completion in Jun 2026, 10 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 23, 2026: start Sep 2025 → Jul 2025, primary completion Mar 2026 → Jun 2026 and completion Mar 2026 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 5, 2025
First posted
Sep 11, 2025
StartActual
Jul 9, 2025was Sep 2025
Primary completionActual
Jun 7, 2026was Mar 2026
CompletionActual
Jun 7, 2026was Mar 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Istanbul Physical Medicine and Rehabilitation Training and Research Hospital · Istanbul, Turkey (Türkiye)
Show 1 removed
  • Istanbul Physical Medicine and Rehabilitation Training and research Hospital · Istanbul, Turkey (Türkiye)
Oct 27, 2026
Start date
Sep 8, 2025→Jul 9, 2025
Oct 23, 2026
Primary completion
Mar 8, 2026→Jun 7, 2026
Oct 23, 2026
Study completion
Mar 8, 2026→Jun 7, 2026
Oct 23, 2026
Enrollment
62→61
Oct 23, 2026
Eligibility
Maximum age none→18 Years
Oct 27, 2026
Primary outcomes
1 edited, 2 description edited
What changed in the outcomes
  • EditedChild Sleep Quality Assessed by a 33-Item Parent-Reported Questionnaire Adapted From the Children's Sleep Habits Questionnaire (CSHQ)Time frame: Day 1 (single assessment at baseline)
  • DescriptionCaregiver Burden Assessed by Zarit Burden Interview (ZBI): how it is measured was reworded
  • DescriptionCaregiver Sleep Quality Assessed by Pittsburgh Sleep Quality Index (PSQI): how it is measured was reworded
Oct 27, 2026
Secondary outcomes
5 description edited
What changed in the outcomes
  • DescriptionCaregiver Psychological Status Assessed by Hospital Anxiety and Depression Scale (HADS): how it is measured was reworded
  • DescriptionChild Functional Level Assessed by Gross Motor Function Classification System (GMFCS): how it is measured was reworded
  • DescriptionCommunication Function Assessed by Communication Function Classification System (CFCS): how it is measured was reworded
  • DescriptionManual Ability Assessed by Manual Ability Classification System (MACS): how it is measured was reworded
  • DescriptionSpasticity Assessed by Modified Ashworth Scale (MAS): how it is measured was reworded
Oct 27, 2026
Show all 3 updates
  1. Nov 3, 2026
    Minor edits only
    + 1 other change: data sharing statement
  2. Oct 27, 2026
    1 site added, 1 site removed
    Show site
    • Istanbul Physical Medicine and Rehabilitation Training and Research Hospital · Istanbul, Turkey (Türkiye)
    Show 1 removed
    • Istanbul Physical Medicine and Rehabilitation Training and research Hospital · Istanbul, Turkey (Türkiye)
    Eligibility Maximum age none→18 Years
    Primary outcomes 1 edited, 2 description edited
    What changed in the outcomes
    • EditedChild Sleep Quality Assessed by a 33-Item Parent-Reported Questionnaire Adapted From the Children's Sleep Habits Questionnaire (CSHQ)Time frame: Day 1 (single assessment at baseline)
    • DescriptionCaregiver Burden Assessed by Zarit Burden Interview (ZBI): how it is measured was reworded
    • DescriptionCaregiver Sleep Quality Assessed by Pittsburgh Sleep Quality Index (PSQI): how it is measured was reworded
    Secondary outcomes 5 description edited
    What changed in the outcomes
    • DescriptionCaregiver Psychological Status Assessed by Hospital Anxiety and Depression Scale (HADS): how it is measured was reworded
    • DescriptionChild Functional Level Assessed by Gross Motor Function Classification System (GMFCS): how it is measured was reworded
    • DescriptionCommunication Function Assessed by Communication Function Classification System (CFCS): how it is measured was reworded
    • DescriptionManual Ability Assessed by Manual Ability Classification System (MACS): how it is measured was reworded
    • DescriptionSpasticity Assessed by Modified Ashworth Scale (MAS): how it is measured was reworded
    + 2 other changes: description and data sharing statement
  3. Oct 23, 2026
    Start date Sep 8, 2025→Jul 9, 2025
    Primary completion Mar 8, 2026→Jun 7, 2026
    Study completion Mar 8, 2026→Jun 7, 2026
    Enrollment 62→61
    + 4 other changes: verification date, description, conditions and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07168577
Lead sponsor
Selim Sezikli
Responsible party
Selim Sezikli (Medical Doctor, Specialist in Physical Medicine and Rehabilitation, Istanbul Physical Medicine Rehabilitation Training and Research Hospital) — Sponsor-investigator
First posted
Sep 11, 2025
Start date
Jul 9, 2025
Primary completion
Jun 7, 2026
Completion
Jun 7, 2026
Last update
Nov 3, 2026

Study contacts

Selim Sezikli, MD
principal investigator · Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion